| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000024885 |
| Receipt No. | R000028637 |
| Scientific Title | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia |
| Date of disclosure of the study information | 2016/11/17 |
| Last modified on | 2020/05/20 (Ver. 9) |
| Basic information | ||
| Public title | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia | |
| Acronym | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia | |
| Scientific Title | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia | |
| Scientific Title:Acronym | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia | |
| Region |
|
|
| Condition | ||
| Condition | Interstitial pneumonia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Investigation of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia |
| Basic objectives2 | Bio-availability |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Percentage of subsets of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | -Patients with interstitial pneumonia
-Willingness and ability to give written Informed Consent |
|||
| Key exclusion criteria | -Is unlikely to cooperate with the requirements of the study including having the ability to communicate with the investigator appropriately. | |||
| Target sample size | 100 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Juntendo University school of medicine | ||||||
| Division name | Department of respiratory medicine | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo, JAPAN | ||||||
| TEL | 03-5802-1063 | ||||||
| nor@juntendo.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Juntendo University school of medicine | ||||||
| Division name | Department of respiratory medicine | ||||||
| Zip code | 113-8431 | ||||||
| Address | 3-1-3 Hongo, Bunkyo-ku, Tokyo, JAPAN | ||||||
| TEL | 03-5802-1063 | ||||||
| Homepage URL | |||||||
| nor@juntendo.ac.jp | |||||||
| Sponsor | |
| Institute | Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Juntendo University Research Ethics Committee |
| Address | 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan |
| Tel | 03-3813-3111 |
| chiken@juntendo.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | The method of recruitment;
Subjects having any of the inclusion criteria will be recruited from our outpatient clinic at Juntendo University Hospital and Saitama Medical University Hospital by March 31, 2020. We examine the subsets of lymphoid cells in bronchoalveolar lavage fluid of interstitial pneumonia. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028637 |